Stemtech Corporation
STEK·OTC Markets OTCID·Healthcare
0.00010.0000 (0.00%)today
At close: Oct 20, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close0.0001
Open0.0001
Day range—
52-week range0.00000.0090
Off day high0.00%
Off 52-week high−98.89%
Volume200.00K
Avg. volume (3M)4.16M
Market cap299.70K
EPS (TTM)-0.0100
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.43
Shares outstanding3.00B
Short interest—
Earnings date—
Analyst target—
Profit margin−156.00%
Against its peers
Compare in full ›| STEK | ORGO | RGC | BRTX | CELZ | CLGN | |
|---|---|---|---|---|---|---|
| Market cap | 299.70K | 131.89M | 4.91B | 2.09M | 5.73M | 6.84M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -3.3 | — | -0.1 | -0.9 | -9.3 |
| Price/book | 0.0 | 0.9 | 367.0 | 0.6 | 0.6 | 1.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −97.85% | −75.89% | −32.58% | −95.14% | −82.02% | −83.49% |
| Today | 0.00% | +3.40% | −8.18% | −1.31% | +1.71% | −3.73% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All STEK news ›Physician Research Points to a New Frontier for Stemtech Corporation: Nutritional Activation of the Body's Endogenous Regenerative System
Corsicana Daily Sun Dr. Zahoorudin proposes expanding Stemtech's pioneering "Release → Circulate → Migrate" model into a broader research framework connecting nutrition, cellular energy, vascular signaling, stem-cell niches and endogenous…
From articles in the 4Search news index.